Contribution of imidazoline receptors and α2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine

Journal of Hypertension

Volumn 25, Issue 1, 2007, Pages 147-155

  Chan, Candy K S ^a   Burke, Sandra L ^a   Head, Geoffrey A ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b NONE   (Australia)

Author keywords

Imidazoline receptors; Rilmenidine; Rostral ventrolateral medulla; Sympathetic baroreflex; 2 adrenoceptors

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORBADRINE; IDAZOXAN; IMIDAZOLINE RECEPTOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; RILMENIDINE; URETHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HYPERTENSION; HYPOTENSION; MALE; MEDULLA OBLONGATA; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RABBIT; RENAL SYMPATHETIC NERVE ACTIVITY; SINGLE DRUG DOSE; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 33845364824     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3280105ef0     Document Type: Article

References (35)

1. Li G, Wang X, Abdel-Rahman AA. Neuronal norepinephrine responses of the rostral ventrolateral medulla and nucleus tractus solitarius neurons distinguish the I1- from the alpha2-receptor-mediated hypotension in conscious SHRs. J Cardiovasc Pharmacol 2005; 46:52-62.
2. Gomez RE, Ernsberger P, Feinland G, Reis DJ. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur J Pharmacol 1991; 195:181-191.
3. Head GA, Burke SL. Relative importance of medullary brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetised rabbit. J Hypertens 1998; 16:503-517.
4. Head GA, Burke SL. Comparison of renal sympathetic baroreflex effects of rilmenidine and alpha-methylnoradrenaline in the ventrolateral medulla of the rabbit. J Hypertens 2000; 18:1263-1276.
5. Chalmers J, Pilowsky P. Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure. J Hypertens 1991; 9:675-694.
6. 2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents. J Auton Nerv Syst 1998; 72:163-169.
7. Chan CK, Burke SL, Zhu H, Piletz JE, Head GA. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine. Neuroscience 2005; 132:991-1007.
8. Wang X, Li G, Abdel-Rahman AA. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension. Eur J Pharmacol 2005; 514:191-199.
9. Head G, Burke S, Sannajust F. Involvement of imidazoline receptors in the baroreflex effects of rilmenidine in conscious rabbits. J Hypertens 2001; 19:1615-1624.
10. Head GA, Burke SL, Chan CKS. Central imidazoline receptors and centrally acting anti-hypertensive agents. Clin Exp Hypertens 1997; 19:591-605.
11. Jovanovska V, Eitle E, Harris PJ. Effects of rilmenidine on proximal tubular fluid absorption in rats. Clin Exp Pharmacol Physiol 2004; 31:348-353.
12. Janssen BJ, Lukoshkova EV, Head GA. Sympathetic modulation of renal blood flow by rilmenidine and captopril: central versus peripheral effects. Am J Physiol 2002; 282:F113-F123.
13. Li YW, Dampney RAL. Clonidine and rilmenidine suppress hypotension-induced fos expression in the lower brainstem of the conscious rabbit. Neuroscience 1995; 66:391-402.
14. Koenig-Berard E, Tierney C, Beau B, Delbarre G, Lhoste F, Labrid C. Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats. Am J Cardiol 1988; 61:22D-31D.
15. Szabo B. Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol Ther 2002; 93:1-35.
16. Dorward PK, Riedel W, Burke SL, Gipps J, Korner PI. The renal sympathetic baroreflex in the rabbit Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ Res 1985; 57:618-633.
17. Head GA, Burke SL, Chan CK. Site and receptors involved in the sympathoinhibitory actions of rilmenidine. J Hypertens Suppl 1998; 16:S7-S12.
18. Chan CKS, Head GA. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine. J Hypertens 1996; 14:855-864.
19. Ricketts JH, Head GA. A five parameter logistic equation for investigating asymmetry of curvature in baroreflex studies. Am J Physiol 1999; 277:R441-R454.
20. Snedecor GW, Cochran WG. Statistical methods. Ames, Iowa: Iowa State University Press; 1980.
21. Dampney RAL, Goodchild AK, Robertson LG, Montgomery W. Role of ventrolateral medulla in vasomotor regulation: a correlative anatomical and physiological study. Brain Res 1982; 249:223-235.
22. 2A-adrenoceptors. Eur J Pharmacol 1989; 167:95-104.
23. Head GA, Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem 2006; 4:17-32.
24. Ernsberger P, Friedman JE, Koletsky RJ. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J Hypertens Suppl 1997; 15:S9-S23.
25. Flamez A, De Backer J-P, Czerwiec E, Ladure P, Vauquelin G. Pharmacological characterization of I1 and I2 imidazoline receptors in human striatum. Neurochem Int 1997; 30:25-29.
26. 3H]idazoxan and some other alpha2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol Pharmacol 1989; 35:324-330.
27. Heemskerk FM, Dontenwill M, Greney H, Vonthron C, Bousquet P. Evidence for presynaptic high affinity imidazoline-specific binding sites in the bovine brainstem. Ann NY Acad Sci 1999; 881:185-188.
28. Milner TA, Rosin DL, Lee A, Aicher SA. Alpha (2A)-adrenergic receptors are primarily presynaptic heteroreceptors in the C1 area of the rat rostral ventrolateral medulla. Brain Res 1999; 821:200-211.
29. Bruban V, Estato V, Schann S, Ehrhardt JD, Monassier L, Renard P, et al. Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation. Circulation 2002; 105:1116-1121.
30. Van den Buuse M, Head GA. Role of central GABA in the regulation of blood pressure and the development of hypertension in the SHR. In: Saito H, Minami M, Parvez SH, Yamori Y, editors. New advances in SHR research - pathophysiology and pharmacology. Zeist: VSP Press; 1995. pp. 77-97.
31. Licata G, Scaglione R,Guillet C, Capuana G, Parrinello G, Indovina A, et al. Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation. J Hum Hypertens 1993; 7:153-157.
32. Kline RL, Cechetto DF. Renal effects of rilmenidine in anesthetized rats: importance of renal nerves. J Pharmacol Exp Ther 1993; 266:1556-1562.
33. Mukaddam-Daher S, Gutkowska J. Atrial natriuretic peptide is involved in renal actions of moxonidine. Hypertension 2000; 35:1215-1220.
34. Vayssettes-Courchay C, Bouysset F, Cordi A, Laubie M, Verbeuren TJ. Effects of medullary alpha2-adrenoceptor blockade in the rat. Eur J Pharmacol 2002; 453:287-297.
35. Huangfu D, Goodwin WB, Guyenet PG. Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats. Am J Physiol 1995; 268:R1429-R1441.